Navigation Links
Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board
Date:7/12/2013

WORCESTER, Mass. and TORONTO, July 12, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced particulars of the conference call it will be hosting featuring members of the Antigen Express, Inc. (www.antigenexpress.com) Scientific Advisory Board.

The conference call will take place on Wednesday, August 14, 2013 at 10 a.m. EDT.  Call-in particulars will be announced prior to the call.

The following members of the Antigen Express Scientific Advisory Board will be the panelists on the call:

  • Dr. Gary H. Lyman, MD, MPH, FACP, FRCP (Edin), FASCO is a Professor of Medicine at Duke University School of Medicine, Director of the Comparative Effectiveness and Outcomes Research Program, a Senior Fellow at the Duke Center for Clinical Health Policy Research, and a member of the Duke Cancer Institute and Duke Center for Personalized Medicine.  An ASCO member since 1977, Dr. Lyman is a member of the ASCO Board of Directors and Chair-Elect of the Clinical Practice Guidelines Committee and serves on the Editorial Board of the Journal of Clinical Oncology.
  • Dr. Gabriel N. Hortobagyi, MD, FACP chairs the department of Breast Medical Oncology and directs the Breast Cancer Research Program at the University of Texas M.D. Anderson Cancer Center, where he also serves as Professor of Medicine and holds the Nellie B. Connally Chair in Breast Cancer.
  • Dr. Ian Krop, MD, PhD is an Assistant Professor of Medicine and Director of Clinical Research for the Breast Oncology Center at the Dana-Farber Cancer Institute, Harvard Medical School.
  • Dr. Keith L. Knutson, PhD is Oncology Program
    '/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
2. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
3. Generex Announces Date of Annual Stockholders Meeting
4. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
5. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
6. Generex Secures Commitments for $3.6M Capital Raise
7. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
8. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
9. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
10. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
11. Averica Discovery Announces Winner of First Averica Award for Supercritical Fluid Chromatography (SFC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sep. 02, 2015 ... has announced the addition of Jain PharmaBiotech,s new ... and Companies" to their offering. ... based on technologies and applications. The report starts ... for estimation of markets. Technologies include array comparative ...
(Date:9/2/2015)... , Sep. 02, 2015 ... http://www.researchandmarkets.com/research/bvxxkf/cytogenetics ) has announced the addition of ... Technologies, Markets and Companies" to their ... includes several technologies besides fluorescence in situ ... multicolor FISH. Molecular cytogenetics includes application of ...
(Date:9/2/2015)... 2, 2015 Australian prostate cancer technology company ... science prize recognising ,outstanding, science that uses its patented ... launch a novel prostate cancer diagnostic test known as ... consortium taking out the peer-reviewed Australian Museum Eureka Science ... This prize is awarded for ground breaking ...
(Date:9/2/2015)... NESS ZIONA, Israel , September ... BVXV, TASE: BVXV) today announced the intent of the National ... U.S. National Institutes of Health (NIH) within the Department of ... 2 trial to be held in the United ... examine the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 ...
Breaking Biology Technology:Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... , , Bodo Eickhoff and Jrgen van der Bosch , ... D-23845 Borstel, Germany. , Tel.: +49 4537 188458 Fax: +49 4537 ... Abstract , This ... improving PCR efficiency: the TaqMaster. With this enhancer, an integral , ...
... , , , , , , ... RT-PCR has become an essential method that allows researchers to determine , ... the organism, tissue or cell of interest. The basic protocol involves ... present in the sample, followed , by amplification of the gene(s) ...
... , , , Kathryn L. Dudeck and Wendy A. Dustman ... Sciences, , , , , , , ... This application describes the use of the MasterTaq polymerase kit for , ... this polymerase, it was possible to amplify a 675 bp region of the amoA ...
Cached Biology Technology:Enhancing PCR* Efficiency with MasterTaq 2Enhancing PCR* Efficiency with MasterTaq 3Enhancing PCR* Efficiency with MasterTaq 4Enhancing PCR* Efficiency with MasterTaq 5cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 2cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 3cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 4cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 5cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 6Amplification of the amoA Gene of Nitrosococcus oceani Bacteria Using , Eppendorf MasterTaq 2Amplification of the amoA Gene of Nitrosococcus oceani Bacteria Using , Eppendorf MasterTaq 3
(Date:9/1/2015)... 1, 2015  Automation and pre-processing are reducing ... screening. This is the first step toward a ... become unintrusive. An assortment of portal scanners, biometric ... investigations will transform the passenger screening process. ... Global Airport Passenger Screening Market ( http://www.frost.com/nf2b ...
(Date:8/25/2015)... LAKE CITY and BELLEVUE, Wash. ... global leader in advanced robotic systems, announced today it ... robotic unmanned ground vehicle (UGV), at the National Tactical ... City.  The Guardian S is the ... the culmination of years of research and in-field trials ...
(Date:8/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... Card Alliance and the EMV Migration Forum.  ... Card Alliance Latin America (SCALA) Chapter provides NXT-ID, Inc. ... leaders promoting adoption of smart card technology. ...
Breaking Biology News(10 mins):The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4
... sclerosis (MS), neuroradiologists and neurologists of the University hospitals ... inflammatory tissue damage, most of which had remained unrecognized ... contrast medium, Gadofluorine M, in magnetic resonance imaging. The ... of the renowned medical journal Brain . ...
... Germany have discovered that methadone, an agent used to ... against leukemia cells, including treatment resistant forms of the ... 1 issue of Cancer Research , a journal ... methadone holds promise as a new therapy for leukemia, ...
... hide their top mate choice, reveals a new study published ... Cell Press journal. They feign disinterest in females ... rival, the tricky males direct their first sexual advances toward ... known to copy other males, mate choices, the researchers noted. ...
Cached Biology News:Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model 2Lab study shows methadone breaks resistance in untreatable forms of leukemia 2Male fish deceive rivals about their top mate choice 2
... Lumat tube luminometer provides the sensitivity and ... luminometer. Advanced digital photon counting with selected ... of spectral demands. Equipped with up to ... suited for reporter gene assays as well ...
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
... The Corning CellBIND surface is produced ... makes a more hydrophilic surface giving ... cell growth and yields. CellBIND enhances ... conditions, including reduced serum or serum-free ...
Biology Products: